Patients with Papillary Thyroid Carcinoma at Intermediate Risk of Recurrence According to American Thyroid Association Criteria Can Be Reclassified as Low Risk When the Postoperative Thyroglobulin Is Low-Reference-Cited by-同舟云学术

Patients with Papillary Thyroid Carcinoma at Intermediate Risk of Recurrence According to American Thyroid Association Criteria Can Be Reclassified as Low Risk When the Postoperative Thyroglobulin Is Low

Published:2015-11 Issue:11 Volume:25 Page:1243-1248
ISSN:1050-7256
Container-title:Thyroid
language:en
Short-container-title:Thyroid

Author:

Rosario Pedro Weslley¹²,Furtado Mariana de Souza¹³,Mourão Gabriela Franco¹²,Calsolari Maria Regina²

Affiliation:

1. Postgraduation Program, Santa Casa de Belo Horizonte, Minas Gerais, Brazil.

2. Endocrinology Service, Santa Casa de Belo Horizonte, Minas Gerais, Brazil.

3. IMES/Famevaço, Faculdade de Medicina do Vale do Aço, Ipatinga, Minas Gerais, Brazil.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/thy.2015.0294

Reference39 articles.

1. Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer

2. Postoperative radioactive iodine administration for differentiated thyroid cancer patients

3. Estimating Risk of Recurrence in Differentiated Thyroid Cancer After Total Thyroidectomy and Radioactive Iodine Remnant Ablation: Using Response to Therapy Variables to Modify the Initial Risk Estimates Predicted by the New American Thyroid Association Staging System

4. Delayed risk stratification, to include the response to initial treatment (surgery and radioiodine ablation), has better outcome predictivity in differentiated thyroid cancer patients

5. Spontaneous remission in thyroid cancer patients after biochemical incomplete response to initial therapy

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Temporal Evolution and Prognostic Role of Indeterminate Response Sub-Groups in Patients with Differentiated Thyroid Cancer after Initial Therapy with Radioiodine;Cancers;2023-02-16

2. Radioactive Iodine Therapy Decreases the Recurrence of Intermediate-Risk PTC With Low Thyroglobulin Levels;The Journal of Clinical Endocrinology & Metabolism;2023-01-30

3. Radioiodine (131I) treatment decision-making for low- and intermediate-risk differentiated thyroid cancer;Archives of Endocrinology and Metabolism;2023-01-18

4. The effect of thyroid hormone withdrawal performed to evaluate the success of I-131 ablation on quality of life and psychological symptoms in female patients with low-risk differentiated thyroid cancer;Journal of Health Sciences and Medicine;2023-01-12

5. CACA guidelines for holistic integrative management of thyroid cancer;Holistic Integrative Oncology;2022-11-08